Cooley advised RAPT Therapeutics, while Davis Polk advised the joint book-running managers in the offering. RAPT Therapeutics, Inc. executed a $75 million SEC-registered follow-on offering of 4,054,055...
RAPT Therapeutics’ $75 Million Common Stock Offering
Denali Therapeutics’ $316 Million Public Offering
Wilson Sonsini Goodrich & Rosati advised Denali Therapeutics on the deal, while Davis Polk advised the representatives of the several underwriters. Denali Therapeutics, a biopharmaceutical company...
EDAP TMS’s $23 Million Follow-on Offering
Davis Polk represented Jefferies LLC, the sole book-running manager, in the offering. EDAP TMS S.A. executed $23 million public offering of 3,066,667 American Depositary Shares (which includes...
SVB Financial’s $2.25 Billion Offerings of Notes and Preferred Stock
Davis Polk advised the sole book-running manager and representative of the several underwriters for the offerings. SVB Financial Group executed the offerings of $650 million aggregate...
SVB Financial Group’s $1.25 Billion Stock Offering
Davis Polk advised the sole underwriter, Goldman Sachs & Co. LLC, in the offering. SVB Financial Group. completed a $1.25 billion public offering of common stock. The common...
IDEAYA Biosciences’ $92 Million Common Stock Offering
Latham & Watkins advised IDEAYA Biosciences, while Davis Polk advised the underwriters in the offering. IDEAYA Biosciences, Inc. executed its public offering of 5,333,333 shares of common...
RAPT Therapeutics’ $143.7 Million Equity Offering
Cooley advised RAPT Therapeutics, while Davis Polk advised the joint book-running managers in the offering. with a $143.7 million SEC-registered follow-on offering of 4,356,060 shares of...
Accuray’s Private Exchange Offers
Davis Polk advised Accuray Incorporated in the deal. Accuray Incorporated executed a private exchange of approximately $82.1 million aggregate principal amount of its outstanding 3.75% convertible...
Ionis Pharmaceuticals’ $632.5 Million Convertible Senior Notes Offering
Davis Polk advised the representatives of the several purchasers in offering. Ionis Pharmaceuticals, Inc. executed its offering of an aggregate principal amount of $632.5 million of its...
Skillz’s $883 Million Stock Offering
Davis Polk advised representatives of the underwriters in the offering. Skillz, Inc. executed its $883 million offering of 36,800,000 shares of Class A common stock, which includes...